Who owns the YORLIVI trademark?

The YORLIVI trademark is owned by Dr. Falk Pharma GmbH.

What class is the YORLIVI trademark registered in?

The YORLIVI trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for YORLIVI?

The USPTO serial number for YORLIVI is 79442843.

What is the registration number for YORLIVI?

YORLIVI is registered under USPTO registration number 0.

Sealvo

Home Search: YORLIVIYORLIVI #79442843

Back

Updated Oct 12, 2026·8 searches this week

View on USPTO TSDR Find similar marks

YOR

USPTO Trademark Record

PENDING

YORLIVI

SN 79442843·Reg 0·Filed Oct 21, 2025

Owner Dr. Falk Pharma GmbH

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

YORLIVI (Serial No. 79442843), Registration No. 0, is a pending US trademark filed on Oct 21, 2025 by Dr. Falk Pharma GmbH. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

YORLIVI (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Oct 21, 2025

SERIAL

79442843

REG#

Filing Information

StatusPENDING

Filing DateOct 21, 2025

Serial Number79442843

Registration No.0

Status DateAug 25, 2026

Published for OppositionAug 25, 2026

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

20 events

PUBLISHED FOR OPPOSITION

Aug 25, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 25, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Aug 20, 2026

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 19, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Aug 05, 2026

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Aug 05, 2026

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 27, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 23, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 23, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 23, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Apr 30, 2026

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Apr 11, 2026

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Apr 11, 2026

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION WRITTEN

Mar 09, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Mar 09, 2026

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

ASSIGNED TO EXAMINER

Mar 07, 2026

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 06, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Mar 06, 2026

APPLICATION FILING RECEIPT MAILED

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Mar 04, 2026

LIMITATION FROM ORIGINAL APPLICATION ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Feb 05, 2026

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Dr. Falk Pharma GmbH

Additional USPTO filings from the same owner.

JOR

JORVEZA

79213908

Dr. Falk Pharma GmbH

REGISTERED

JOR

JORVEZA

98599481

Dr. Falk Pharma GmbH

REGISTERED

IMF

IMFALDA

98599636

Dr. Falk Pharma GmbH

REGISTERED

UZU

UZUNCA

79437448

Dr. Falk Pharma GmbH

PENDING

Other Marks by Marcus P. Dolce

Additional USPTO filings handled by the same attorney of record.

HAM

HAMMOND ROTO FINISH

87644410

REGISTERED

ROT

ROTO FINISH

87644503

REGISTERED

LOG

LogoMark

98863732

REGISTERED

HAC

HACYO

98863783

REGISTERED

YORLIVI

Run a conflict check

Other Marks by Dr. Falk Pharma GmbH

Other Marks by Marcus P. Dolce

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company